2'-hydroxyflavanone has been researched along with Lung Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Awasthi, S; Chikara, S; Horne, D; Salgia, R; Singhal, J; Singhal, SS | 1 |
Chang, HR; Chen, PN; Chu, SC; Hsiao, YC; Hsieh, YS; Kuo, WH; Lin, TH; Yang, WE | 1 |
2 other study(ies) available for 2'-hydroxyflavanone and Lung Neoplasms
Article | Year |
---|---|
RLIP inhibition suppresses breast-to-lung metastasis.
Topics: Animals; ATP-Binding Cassette Transporters; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Flavanones; GTPase-Activating Proteins; Humans; Lung; Lung Neoplasms; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Metastasis; Xenograft Model Antitumor Assays | 2019 |
Flavanone and 2'-OH flavanone inhibit metastasis of lung cancer cells via down-regulation of proteinases activities and MAPK pathway.
Topics: Animals; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Flavanones; Humans; Lung Neoplasms; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Molecular Structure; Neoplasm Metastasis; Peptide Hydrolases; Phosphorylation; Xenograft Model Antitumor Assays | 2007 |